ADMET and Insilico docking Studies of Erlotinib Leads with EGFR Protein for the Treatment of Lung Cancer.
Soundarya K
ADMET and Insilico docking Studies of Erlotinib Leads with EGFR Protein for the Treatment of Lung Cancer. - DCB
ADMET and Insilico docking Studies of Erlotinib Leads with EGFR Protein for the Treatment of Lung Cancer. - DCB